Wei Wei

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

21h-index2.5kcitations269works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(98), CAR-T cell therapy research(66), Melanoma and MAPK Pathways(44), Acute Myeloid Leukemia Research(42), Lung Cancer Treatments and Mutations(32)

Publications269 total

Abstract PS4-03-15: Repurposing eliglustat as an anti-cancer agent for triple-negative breast cancer
Clinical Cancer Research·2026
A joint distribution for indexes of extremes with applications to climate change
Statistics and Its Interface·2026
Figure S5 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma
2025Open Access
Figure S7 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma
2025Open Access
Figure S1 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma
2025Open Access
Figure S6 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma
2025Open Access
Tables S1 and S2 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma
2025Open Access
Figure S3 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma
2025Open Access
Figure S2 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma
2025Open Access
Figure S8 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma
2025Open Access
Figure S4 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma
2025Open Access
Association between chronic kidney disease and sarcopenia and emerging treatment strategies
Frontiers in Nutrition·2025· 1 citedOpen Access
CD27, CD62L and ESAM define a multipotent progenitor population with megakaryocytic potential
Blood·2025
Management and outcomes of patients diagnosed with chronic myeloid leukemia in blast Phase: A multicenter analysis by the h jean khoury cure CML consortium
Blood·2025Open Access
Outcomes of patients (pts) with higher-risk myelodysplastic syndromes (HR-MDS) treated with hypomethylating agents (HMA) + venetoclax (VEN) – a large analysis from the international consortium for MDS (icMDS) validate database
Blood·2025Open Access
PMA exerts anti-leukemia effect in Ph+ ALL through activating PKC δ and its down-stream molecules
Cancer Cell International·2025Open Access
The Maximum Negative Hypergeometric Distribution
Journal of Statistical Theory and Practice·2025
Association between complete blood count-derived inflammatory biomarkers and renal failure: a cross-sectional study from NHANES 2007–2020
BMJ Open·2025· 2 citedOpen Access
Optimization of green development for methylene diphenyl diisocyanate industry based on synergistic benefit
Journal of environmental chemical engineering·2025
GIMAP8 could serve as a potential prognostic factor for lung adenocarcinoma and is closely related to immunity
Scientific Reports·2025Open Access
page 1 of 14Next →

Frequent Co-authors

Harriet M. Kluger(12), David L. Rimm(8), Lucia B. Jilaveanu(7), Amit Mahajan(6), Veronica Chiang(5), Sarah A. Weiss(5), Sarah B. Goldberg(4), Yuval Kluger(4), Gail D. Anderson(4), Daniel Zelterman(4), Dijana Djureinovic(4), Rory M. Shallis(4), Nikolai A. Podoltsev(4), Jan Philipp Bewersdorf(4), Steven D. Gore(4), Amer M. Zeidan(4), Jiwang Zhang(4), Lajos Pusztai(4), Scott Gettinger(3), Thuy Tran(3)